Home>US Stocks>Moderna Inc.
shareSHARE

MRNA

Moderna Inc.

Performance

Today’s LowNA
    Today’s HighNA
    52W LowNA
      52W HighNA
      Open PricePrev. CloseVolumeAvg. Volume
      NANANANA

      Company Statistics

      Market CapP/B RatioP/E RatioEnterprise Value
      $59.42 B21.50NA$58.12 B
      Div. YieldBook ValueEPS(TTM)ROE
      NA6.99-0.59NA

      About the Company

      Moderna, Inc., a clinical stage biotechnology company, develops therapeutics and vaccines based on messenger RNA for the treatment of infectious diseases, immuno-oncology, rare diseases, and cardiovascular diseases. As of February 15, 2019 the compan
      Organisation
      Moderna Inc.
      Industry
      Biotechnology
      Headquarters
      Cambridge, MA
      ⓒ 2016-2021 Groww. All rights reserved, Built with in India
      ABOUT GROWW
      keyboard_arrow_down